市場調查報告書

霍亂疫苗市場 - 分析,佔有率,趨勢,市場規模,包含預測:2016年∼2027年 (COVID-19的影響)

Cholera Vaccines Market, By products (Dukoral, Shanchol, Vaxchora and others), And Geography (North America, Europe, Asia Pacific, And Rest Of The World) - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated

出版商 AnalystView Market Insights 商品編碼 950989
出版日期 內容資訊 英文 216 Pages
商品交期: 2-3個工作天內
價格
霍亂疫苗市場 - 分析,佔有率,趨勢,市場規模,包含預測:2016年∼2027年 (COVID-19的影響) Cholera Vaccines Market, By products (Dukoral, Shanchol, Vaxchora and others), And Geography (North America, Europe, Asia Pacific, And Rest Of The World) - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated
出版日期: 2020年07月01日內容資訊: 英文 216 Pages
簡介

北美和歐洲,霍亂疫苗市場全體記錄了最高的收益。2016年的收益為2億1000萬美元以上,歐洲獨佔市場。亞太地區、南美等發展中地區,因為霍亂的發生率高,視為成長快速的地區市場區隔。

本報告提供全球霍亂疫苗市場相關調查分析,市場概要,市場動態,各市場區隔的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 霍亂疫苗市場概要

第2章 摘要整理

第3章 霍亂疫苗市場主要趨勢

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場未來趨勢

第4章 霍亂疫苗產業分析

  • 企業活動分析
  • 法律規範分析
  • 價值鏈分析

第5章 霍亂疫苗市場形勢

  • 市場佔有率分析
  • 主要創新者

第6章 霍亂疫苗市場:各產品

  • 概要
  • Dukoral
  • Shanchol
  • Vaxchora
  • 其他

第7章 霍亂疫苗市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 主要供應商分析

  • Merck & Co.
  • GlaxoSmithKline
  • Sanofi
  • Johnson & Johnson
  • Pfizer, Inc.

第9章 分析師的見解

第10章 附錄

目錄

REPORT HIGHLIGHT The cholera vaccines market is estimated to represent a global market of USD 82.3 million by 2021-2019 with growth rate of 10.3%.

Cholera is a bacterial infection (Vibrio cholerae), primarily caused due to the contaminated food or water intake. Symptoms of it can be mild i.e. watery diarrhea and profuse vomiting, but it can lead to be severe. Normally, patients are treated with oral rehydration solution and in severe condition intake of intravenous fluid is required.

The market is divided into products such as Dukoral, Shanchol, Vaxchora and others. Dukoral, and Shanchol dominated the market. WHO has pre-qualified these two cholera vaccines which will support the market growth. Dukoral was the first oral cholera vaccine to get approval in European Union (EU) during the year 2004.

COVID-19 IMPACT & Recovery Analysis

The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

Geographically, North America and Europe recorded highest revenue of the total market. Of which, Europe dominated the market with more than USD 210 million revenue in 2016. Developing regions such as Asia Pacific and Latin America are considered to be the fastest growing regional segment owing to the high cholera incidences. For instance, as per the World Health Organization (WHO) statisticscholera spread very rapidly in Latin America which cause nearly 400,000 reported cases and over 4000 reported deaths every year. This fact would in turn boost the demand for cholera vaccines in developing regions, leading to drive the market growth.

Companies such as Merck & Co., GlaxoSmithKline, Sanofi and Pfizer, Inc. are the key players of the market. Collectively these companies accounted for more than 75% revenue share of the global market. Additionally, Novartis AG, Astellas Pharma, Emergent BioSolutions, Takeda Pharmaceuticals, AstraZeneca plc and Mitsubishi Tanabe have also significant presence in this market.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year - 2016 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHOLERA VACCINES MARKET,BY PRODUCTS

Dukoral

Shanchol

Vaxchora

Others

GLOBAL CHOLERA VACCINES MARKET,BY REGION

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

  • TABLE OF CONTENT CHOLERA VACCINES MARKET OVERVIEW

Study Scope

Base Year

Assumption and Methodology

EXECUTIVE SUMMARY

Key Market Facts

Geographical Scenario

Companies in the Market

CHOLERA VACCINESKEY MARKET TRENDS

Market Drivers

Impact Analysis of Market Drivers

Market Restraints

Impact Analysis of Market Restraints

Market Opportunities

Market Future Trends

CHOLERA VACCINESINDUSTRY STUDY

Company Activity Analysis

Regulatory Framework Analysis

Value Chain Analysis

CHOLERA VACCINES MARKET LANDSCAPE

Market Share Analysis

Key Innovators

CHOLERA VACCINES MARKET - BY PRODUCTS:

Overview

Dukoral

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Shanchol

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Vaxchora

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Others

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

CHOLERA VACCINES MARKET- BY GEOGRAPHY

Introduction

North America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

U.S.

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Canada

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

France

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Germany

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Rest of Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Asia Pacific (APAC)

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

China

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

India

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Rest of APAC

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Rest of the World

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Latin America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

Middle East and Africa

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

KEY VENDOR ANALYSIS

Merck & Co.

Company Overview

SWOT Analysis

Key Developments

GlaxoSmithKline

Company Overview

SWOT Analysis

Key Developments

Sanofi

Company Overview

SWOT Analysis

Key Developments

Johnson & Johnson

Company Overview

SWOT Analysis

Key Developments

Pfizer, Inc.

Company Overview

SWOT Analysis

Key Developments

360 DEGREE ANALYSTVIEW

APPENDIX

Research Methodology

Abbreviations

Disclaimer

Contact Us

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the CHOLERA VACCINES Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the CHOLERA VACCINES Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

Understanding of the strategies that are being adopted by the key players in this market to stay competitive

Extensive analysis of the key players dominating the competitive landscape of this market

In-depth analysis of the key factors are propelling the growth of the global market

Detailed analysis of the geographic region that will witness the strongest growth

Granular analysis of the current market scenario and the expected market grow

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PESTLE Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Cholera Vaccines Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Figure 10 Cholera Vaccines Market, by Products, 2016 - 2027 (USD Million)
  • Figure 11 Cholera Vaccines Market, by Geography, 2016 - 2027 (USD Million)
  • Table 12 North America Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 13 U.S. Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 14 Canada Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 15 Europe Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 16 France Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 17 Germany Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 18 Asia Pacific Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 19 China Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 20 India Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 21 Latin America Cholera Vaccines Market, 2016 - 2027 (USD Million)
  • Table 22 MEA Cholera Vaccines Market, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1 Research Methdology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Cholera Vaccines Market, by Products, 2016 - 2027 (USD Million)
  • Figure 7 Cholera Vaccines Market, by Geography, 2016 - 2027 (USD Million)